The chokehold that social media has on us, Im trying to hold onto people before they get sucked into the GLP-1 abyss. Glucagon-like-peptide-1 receptor agonists, better known as GLP-1s and even more ubiquitously referred to by brand names Ozempic, Wegovy and Mounjaro, have been dubbed the wonder drugs or culprits behind the dramatic weight loss weve seen across pop culture
However, federal law still prohibits Part D from covering medications used solely for weight loss
Retatrutide Clinical Research Findings The clinical development program for retatrutide has produced compelling data across multiple research endpoints: Weight Loss Efficacy: Phase 2 trials showed dose-dependent weight reduction ranging from 8.7% at the lowest dose to 24.2% at the highest dose over 48 weeks Metabolic Improvements: Participants demonstrated improvements in glycemic control, lipid profiles, and blood pressure measurements Safety Profile: Gastrointestinal effects (nausea, vomiting, diarrhea) were the most common adverse events, occurring in 60-80% of participants but generally rated as mild to moderate in severity Sustained Effects: Weight loss continued throughout the trial period without evidence of plateau, suggesting ongoing metabolic benefits These findings have positioned retatrutide as a leading candidate for advanced metabolic research
Buyer Takeaway: Set a calendar reminder for 72+ hours before your expected billing date the moment you enroll
It is most effective when used in conjunction with healthy eating habits and regular exercise
Taking both increases the chance of serious side effects